Expanded Access Policy

Patients with a serious illness or conditions who have exhausted all available treatment options, often want to know if their Physician can secure early access to investigational medications (ie: products not approved by the Country Regulatory Agency).

Early access is typically through a clinical trial, but in cases where clinical trial participation is not possible, Regulatory Agencies may grant permission to provide a licensed physician with an unapproved product for an individual patient.  This is called Expanded or Compassionate Access.

For further information on our Expanded Access Policy (EAP), click here.